UPDATE: Credit Suisse Downgrades ARIAD Pharmaceuticals (ARIA) to Underperform
Tweet Send to a Friend
(Updated - December 11, 2014 10:25 AM EST)
Credit Suisse downgraded ARIAD Pharmaceuticals (NASDAQ: ARIA) from Neutral to Underperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Credit Suisse downgraded ARIAD Pharmaceuticals (NASDAQ: ARIA) from Neutral to Underperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
